Escuela Andaluza de Salud Pública-ko ikertzaileekin lankidetzan egindako argitalpenak (43)

2024

  1. Economic assessment of abemaciclib for the adjuvant treatment of luminal HER2- breast cancer from the perspective of the Spanish health system

    European Journal of Health Economics

2023

  1. Challenges for Economic Evaluations of Advanced Therapy Medicinal Products: A Systematic Review

    Value in Health, Vol. 26, Núm. 1, pp. 138-150

  2. INES: Interactive tool for construction and extrapolation of partitioned survival models

    Cost Effectiveness and Resource Allocation, Vol. 21, Núm. 1

  3. Pricing and reimbursement mechanisms for advanced therapy medicinal products in 20 countries

    Frontiers in Pharmacology, Vol. 14

  4. The cost-effectiveness of a uniform versus age-based threshold for one-off screening for prevention of cardiovascular disease

    European Journal of Health Economics, Vol. 24, Núm. 7, pp. 1033-1045

2022

  1. Are costs derived from diagnosis-related groups suitable for use in economic evaluations? A comparison across nine European countries in the European Healthcare and Social Cost Database

    European Journal of Health Economics, Vol. 23, Núm. 9, pp. 1563-1575

  2. Development of the European Healthcare and Social Cost Database (EU HCSCD) for use in economic evaluation of healthcare programs

    BMC Health Services Research, Vol. 22, Núm. 1

  3. GACETA SANITARIA in 2021. Protecting the planet to protect health

    Gaceta Sanitaria

  4. How innovation can be defined, evaluated and rewarded in health technology assessment

    Health Economics Review, Vol. 12, Núm. 1

  5. Use of heuristics during the clinical decision process from family care physicians in real conditions

    Journal of Evaluation in Clinical Practice, Vol. 28, Núm. 1, pp. 135-141

2021

  1. A neuroimaging study protocol on the motivational structures of physicians belonging to private and public health: Neuroeconomics in healthcare

    Critical Issues on Changing Dynamics in Employee Relations and Workforce Diversity (IGI Global), pp. 242-265

  2. Correction to: A general framework for classifying costing methods for economic evaluation of health care (The European Journal of Health Economics, (2020), 21, 4, (529-542), 10.1007/s10198-019-01157-9)

    European Journal of Health Economics

  3. GACETA SANITARIA en 2020. Respuesta editorial a la sindemia e implementación de nuevas normas

    Gaceta Sanitaria

  4. Multilevel zero‐one inflated beta regression model for the analysis of the relationship between exogenous health variables and technical efficiency in the spanish national health system hospitals

    International Journal of Environmental Research and Public Health, Vol. 18, Núm. 19

2020

  1. A general framework for classifying costing methods for economic evaluation of health care

    European Journal of Health Economics, Vol. 21, Núm. 4, pp. 529-542

  2. Economic evaluation of the introduction of 4CMenB (Bexsero®) in the national vaccine schedule in Spain

    Gaceta Sanitaria, Vol. 34, Núm. 4, pp. 318-325

  3. Effect of the use of heuristics on diagnostic error in Primary Care: Scoping review

    Atencion Primaria, Vol. 52, Núm. 3, pp. 159-175

  4. Evaluation of new medicines in Spain and comparison with other European countries

    Gaceta Sanitaria, Vol. 34, Núm. 2, pp. 133-140

  5. Evidence-based decision making in public health: special edition of GACETA SANITARIA

    Gaceta Sanitaria, Vol. 34, Núm. 4, pp. 316-317

  6. GACETA SANITARIA en 2019. Trabajando para mejorar la eficiencia en la publicación científica

    Gaceta Sanitaria